Communications
News & Press Release
-
Neurobiogen, "Succeeded in Phase 1 of Obesity and Dementia Treatment..."Discussion on Global Big Pharma Technology Transfer"2024.07.22
-
"Wigobi there"...BioVenture Speeds Research on Native Obesity Drugs.2024.03.26
-
Kim Sang-wook, CEO of Neurobiogen, said, "We will promote the transfer of technology and treatment for dementia and obesity".2024.03.20
-
Neurobiogen "Phase 1 successful treatment for obesity and dementia...Application for Phase 2 of Q2".2024.03.20
-
Neurobiogen, obesity treatment..."It's more effective and safer" than the mainstream GLP-1.2024.03.20
Notice
-
Neurobiogen exhibit booth at '2024 BIO International Convention'.Neurobiogen exhibit booth at '2024 BIO International Convention'. June 3-6, 2024, San Diego USA Booth exhibition No. : #36532024.05.29
-
Neurobiogen and Medica Korea exhibit booth together at '2023 BIO International Convention'.Neurobiogen and Medica Korea exhibit booth together at '2023 BIO International Convention'. June 5-8, 2023, Boston USA Booth exhibition No. : 24642023.05.09